
Healthcare companies are making significant strides in developing drugs and therapeutics for some of the most severe conditions. Positive clinical trial results and improved patient outcomes are driving the need for ongoing medical care and treatment.
Against this backdrop, it could be wise to invest in fundamentally sound medical stocks Medtronic plc (MDT), FONAR Corporation (FONR), and Electromed, Inc. (ELMD), which are trading at a discount relative to their peers.